Donor deferral and resulting donor loss at the American Red Cross Blood Services, 2001 through 2006

Transfusion
Shimian ZouChyang T Fang

Abstract

A large number of blood donors are deferred each year and many of the temporarily deferred donors do not return to donate blood. This study analyzed actual deferral and return donation data from the American Red Cross to further assess the impact of donor deferral on donor availability. Voluntary blood donors who presented between 2001 and 2006 were included in this study. Deferred donors were classified into three groups according to their history of presentation during the prior 2 years: Group 1 with no prior donation or deferral, Group 2 with prior donation but no deferral, and Group 3 with prior deferral. Temporarily deferred donors in Groups 1 and 2 who did not return during the next 3 years were considered lost donors. All indefinitely deferred donors were lost donors. A mean of 12.8 percent of a total of 47,814,370 donor presentations between 2001 and 2006 resulted in a deferral. While majority of the deferrals were related to donor safety reasons, deferrals for recipient safety reasons accounted for 22.6 percent of deferrals or 2.9 percent of total presentations. Temporary and indefinite deferrals for recipient safety-related reasons collectively caused an estimated loss of 647,828 donors during the 6 years. An addition...Continue Reading

References

Jul 27, 2001·Transfusion Medicine Reviews·B Newman
Apr 24, 2004·Transfusion·Edward L MurphyPascale Reich
Jul 28, 2007·Transfusion·Brian CusterEdward L Murphy
Aug 30, 2007·Transfusion·David A Leiby
Dec 8, 2007·Transfusion Medicine Reviews·Shimian ZouLawrence B Schonberger
May 28, 2008·Transfusion·Stephen O CrawfordShimian Zou

❮ Previous
Next ❯

Citations

Aug 17, 2012·Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur̈ Transfusionsmedizin Und Immunham̈atologie·Michael Müller-SteinhardtHarald Klüter
Sep 23, 2010·Asian Journal of Transfusion Science·Naveen Agnihotri
Jan 29, 2013·Anesthesiology Clinics·Samuel M Galvagno, Colin F Mackenzie
Apr 24, 2012·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Farhad RazjouMaryam Zadsar
Aug 30, 2011·Transfusion Medicine Reviews·Anne F Eder
Sep 21, 2010·Transfusion Medicine Reviews·Juergen RingwaldReinhold Eckstein
Aug 25, 2015·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Bushra MoizMadeeha Anwar
Apr 2, 2009·Transfusion·Jay E Menitove
Dec 6, 2008·Transfusion·Jed Gorlin
Mar 15, 2012·Transfusion·Marie-Soleil CloutierGilles Delage
Nov 8, 2012·Transfusion Medicine·K G BadamiD Walkden
Aug 1, 2012·Transfusion·Thelma T GonçalezUNKNOWN NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II), International Component
Oct 11, 2011·Transfusion·Cesar de Almeida NetoUNKNOWN NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II), International Component
Dec 16, 2010·Transfusion·Brian CusterUNKNOWN NHLBI Retrovirus Epidemiology Donor Study-II
Sep 8, 2011·Transfusion·Nan GuoUNKNOWN NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II), International Component
Jul 31, 2013·Transfusion·Wim de KortTanneke Marijt-van der Kreek
Jul 31, 2013·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Alain Mayindu NgomaSeiji Yasumura
Sep 9, 2016·Asian Journal of Transfusion Science·Leila Kasraian, Mohammad Hossein Karimi
Mar 13, 2016·Transfusion·A Mireille BaartPieternel C M Pasker-de Jong
Aug 29, 2014·São Paulo Medical Journal = Revista Paulista De Medicina·Leila Kasraian, Neda Negarestani
Dec 29, 2017·Transfusion Medicine·W de KortK van den Hurk
Apr 5, 2019·Transfusion·Josephine MitchelUNKNOWN Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) South Africa Program
Apr 10, 2019·Transfusion·Thelma T GonçalezUNKNOWN NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II), International Component, Brazil
Jul 4, 2019·Transfusion·Suchitra Pandey, Hua Shan
Jul 25, 2019·BMC Health Services Research·Henshaw Uchechi Okoroiwu, Enosakhare Aiyudubie Asemota

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.